Dental implant co. BioHorizons files for $100M IPO
On Thursday June 24, 2010, 8:39 am EDT
NEW YORK (AP) -- Dental implant maker BioHorizons Inc. on Wednesday filed a registration statement for an initial public offering worth up to $100 million.
The Birmingham, Ala., company makes products such as tooth prosthetics, implants, abutments, and bone and tissue grafts. It also sells medical instruments. The company uses lasers to cut tiny grooves into its Laser-Lok implants, and says those grooves attract connective tissue and reduce bone loss around the implant.
BioHorizons did not disclose how many shares it might sell, or when it might go public. Its proposed ticker symbol is "BHZN."
The company's main business was founded in November 1995, and BioHorizons was incorporated in May 2006. Private equity firm HealthpointCapital LLC bought its primary business in August 2006.
BioHorizons reported an operating loss of $6 million in 2009, on $69 million in sales. It said its revenue grew 15 percent in the first quarter of 2010, to $19 million. The company said its competitors including Biomet, Zimmer Holdings, Dentsply, AstraZeneca's Astra Tech unit.
The book-running managers of the offering and Piper Jaffray and Jefferies & Co., with Canaccord Genuity and Cowen and Co. as co-managers.
"Dental implant co. BioHorizons files for $100M IPO"
Companies: AstraZeneca PLC - DENTSPLY International Inc. - Zimmer Holdings, Inc.
Topics:IPOs
Dental implant, prosthetic, and graft maker BioHorizons registers IPO worth up to $100 million
NEW YORK (AP) -- Dental implant maker BioHorizons Inc. on Wednesday filed a registration statement for an initial public offering worth up to $100 million.
The Birmingham, Ala., company makes products such as tooth prosthetics, implants, abutments, and bone and tissue grafts. It also sells medical instruments. The company uses lasers to cut tiny grooves into its Laser-Lok implants, and says those grooves attract connective tissue and reduce bone loss around the implant.
BioHorizons did not disclose how many shares it might sell, or when it might go public. Its proposed ticker symbol is "BHZN."
The company's main business was founded in November 1995, and BioHorizons was incorporated in May 2006. Private equity firm HealthpointCapital LLC bought its primary business in August 2006.
BioHorizons reported an operating loss of $6 million in 2009, on $69 million in sales. It said its revenue grew 15 percent in the first quarter of 2010, to $19 million. The company said its competitors including Biomet, Zimmer Holdings, Dentsply, AstraZeneca's Astra Tech unit.
The book-running managers of the offering and Piper Jaffray and Jefferies & Co., with Canaccord Genuity and Cowen and Co. as co-managers.
"Dental implant co. BioHorizons files for $100M IPO"
Companies: AstraZeneca PLC - DENTSPLY International Inc. - Zimmer Holdings, Inc.
Topics:IPOs
Dental implant, prosthetic, and graft maker BioHorizons registers IPO worth up to $100 million
posted by Zo Heri at 10:10 AM
0 Comments:
Post a Comment
<< Home